CAMBRIDGE, Mass.--(BUSINESS WIRE)--PixarBio is proud to announce that Laura Morse has joined the Board of Directors as an independent Board Member. PixarBio Corporation, the inventors of NeuroReleaseTM, a morphine strength, non-addictive non opiate pain treatment with expected FDA approval in 2018, is positioning the board for compliance with SEC regulations. Laura Morse will join Chief Executive Officer Frank Reynolds, Chief Administration Officer Katrin Holzhaus, independent Board Member David A. Cass, and independent Board Member Derek Bridges on the Board while serving on the audit and the general & nominating committee.

Laura Morse is Managing Director of Entrepreneurship Ventures Inc. (EVI), a consulting and coaching firm focused on assisting global entrepreneurs to achieve their full potential. Laura joined EVI in 2009 after working with Atlas Venture, assisting the firm’s US and international portfolio companies with teambuilding, human resource strategies, board development, strategic hiring, and leadership development. She also led the human resources function for the firm, coordinating with three offices in Europe and three in the U.S. to design and implement best in class recruitment, compensation, benefits and training programs.

Laura Morse comes to PixarBio having served on relevant boards and committees. She serves as Trustee of the Mass General Physicians Organization on two standing committees, the Compensation and Compliance committees. For over 20 years, Laura has served as Trustee of the Boston Museum of Science and also serves as a Trustee of the Quissett Harbor Preservation Trust. She is a frequent speaker and coach on recruiting, team building, and career planning at workshops around Europe and leading business schools around the world including Solvay (Belgium), Harvard Business School, and MIT-Sloan.

“It’s critical to continue to add leaders with credibility and integrity to our Board of Directors. Laura joins our Board of Directors as we prepare for the rapid expansion of our workforce. I’ve known Laura for over a decade and I’ve watch her lead entrepreneurship projects all over the world. Her business partner Ken Morse was my entrepreneurship professor at MIT-Sloan, and her late father-in-law Richard Morse founded entrepreneurship studies at MIT-Sloan in 1961 so supporting the entrepreneur comes naturally to Laura. The impact the Morse Family has had on entrepreneurship cannot be measured and Laura extends the family mission. Laura has a wide range of skills to bring to the Board, and she’ll be invaluable as we seek to treat over 70,000,000 surgical pain patients per year in the USA,” said Frank Reynolds, CEO of PixarBio.

Laura Morse graduated from the University of Iowa, where she was elected to Mortar Board, a national honor society that recognizes college seniors for distinguished ability and achievement in scholarship, leadership, and service. She is married to world renowned entrepreneur Ken Morse, has two adult daughters and two grandchildren.

About PixarBio Corporation
Cofounded by Frank M. Reynolds, MIT’s Dr. Robert S. Langer, Katrin Holzhaus, and Dr. Jason Criscione, PixarBio researches and develops targeted delivery systems for drugs, cells, or biologics to treat pain, epilepsy, Parkinson’s disease, and spinal cord injury. For more information visit www.pixarbio.com.